2023
DOI: 10.1002/sim.9904
|View full text |Cite
|
Sign up to set email alerts
|

On the estimation of interval censored destructive negative binomial cure model

Jodi Treszoks,
Suvra Pal

Abstract: In this article, a competitive risk survival model is considered in which the initial number of risks, assumed to follow a negative binomial distribution, is subject to a destructive mechanism. Assuming the population of interest to have a cure component, the form of the data as interval‐censored, and considering both the number of initial risks and risks remaining active after destruction to be missing data, we develop two distinct estimation algorithms for this model. Making use of the conditional distributi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 52 publications
0
1
0
Order By: Relevance
“…Unlike right-censored data, 32 , 33 interval-censored data occur for a study where subjects are inspected at regular intervals, and not continuously. 34 36 If a subject experiences the event of interest, the exact survival time is not observed and is only known that the event has occurred between two consecutive inspections. Interval-censored data marked by cure prospect are often observed in follow-up clinical studies (cancer biochemical recurrence or AIDS drug resistance) dealing with events having low fatality and patients monitored at regular intervals.…”
Section: Introductionmentioning
confidence: 99%
“…Unlike right-censored data, 32 , 33 interval-censored data occur for a study where subjects are inspected at regular intervals, and not continuously. 34 36 If a subject experiences the event of interest, the exact survival time is not observed and is only known that the event has occurred between two consecutive inspections. Interval-censored data marked by cure prospect are often observed in follow-up clinical studies (cancer biochemical recurrence or AIDS drug resistance) dealing with events having low fatality and patients monitored at regular intervals.…”
Section: Introductionmentioning
confidence: 99%